Top Markets
Coin of the day
Regulus Therapeutics Inc. Regulus Therapeutics Inc.

Regulus Therapeutics Inc.

RGLS
Classement en actions #17600
Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development... Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development phase, is dedicated to uncovering and advancing novel medications. Based in San Diego, California, the company's core focus is on modulating microRNAs to combat a variety of diseases across the United States. Its current pipeline highlights RG-012, an anti-miR compound engineered to inhibit miR-21, which is currently in a Phase II clinical study for Alport syndrome, a severe renal condition. Another significant candidate, RGLS8429, an anti-miR agent targeting miR-17, is being evaluated in a Phase 1b clinical trial for autosomal dominant polycystic kidney disease. Beyond these clinical programs, Regulus is also cultivating an extensive preclinical portfolio, emphasizing drug candidates with precise, organ-selective delivery strategies. The company was established in 2007.
Prix de l'action
$8.16
Dernière synchronisation: 2025-06-26
Capitalisation boursière
$234.57M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Regulus Therapeutics Inc. (RGLS)

Catégorie

Nombre d'actions en circulation pour Regulus Therapeutics Inc. (RGLS)
Nombre d'actions en circulation au March 2025: 66.17M
Selon les derniers rapports financiers et le cours de l'action de Regulus Therapeutics Inc., le nombre actuel d'actions en circulation est de 66.17M. À la fin de December 2023, l'entreprise avait 18.96M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Regulus Therapeutics Inc. (RGLS) de 2010 à 2026
Actions en circulation à la fin de chaque année
Année Actions en circulation Changez
2026 (TTM) 66.17M 17.44%
2024 56.35M 197.18%
2023 18.96M 24.25%
2022 15.26M 78.05%
2021 8.57M 145.03%
2020 3.50M 102.65%
2019 1.73M 97.97%
2018 871.86K 0.61%
2017 866.58K 96.90%
2016 440.11K 2.73%
2015 428.43K 16.61%
2014 367.42K 14.58%
2013 320.66K 368.55%
2012 68.44K 3,099.49%
2011 2.14K 0.00%
2010 2.14K 0.00%
Actions en circulation pour des entreprises similaires ou concurrentes
Entreprise Actions en circulation Différence Pays
253.90M 283.68%
US
62.19M -6.03%
NL
396.00M 498.42%
US
478.91M 623.71%
AU
- -
CH